Dr. Andrew M. Kaunitz on prescribing systemic HT to older women

Andrew M. Kaunitz, MD

Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine–Jacksonville. Dr. Kaunitz serves on the OBG Management Board of Editors.

Dr. Kaunitz reports that he receives grant or research support from Agile, Bayer, Noven, Teva, and TherapeuticsMD and is a consultant to Actavis, Bayer, Merck and Teva.